You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

New Approach for Conjunctivochalasis Using an Argon Green Laser

Yang, Hyun Seung MD; Choi, Sangkyung MD

Cornea:
doi: 10.1097/ICO.0b013e318255eaaa
Clinical Science
Abstract

Purpose: To evaluate the effectiveness of conjunctivoplasty using an argon green laser in symptomatic patients with conjunctivochalasis (CCh).

Methods: Twenty-nine eyes of 18 patients with various grades of CCh were included in this study. All the patients, who were refractory to the conventional therapy, were treated using an argon green laser. The ocular symptoms and signs, including the CCh grade, the tear Ocular Surface Disease Index, the breakup time, the Schirmer test, and the abnormal ocular surface findings, were evaluated preoperatively and postoperatively.

Results: The mean age of the patients was 69.1 ± 8.4 years. The grade of CCh in 25 eyes (86%) decreased at 6 months after the laser conjunctivoplasty. When the grade reduction rates were calculated, the reduction rates of grades 1, 2, and 3 were 100%, 69%, and 48%, respectively. Most of the patients showed a significant symptomatic improvement, and the Ocular Surface Disease Index scores decreased from 0.41 to 0.22 (P < 0.001). The breakup time increased from 9.1 to 10.2 (P = 0.007), but the Schirmer test results did not show any differences after the surgery (P = 0.257).

Conclusions: Conjunctivoplasty using an argon green laser is a simple and effective choice to treat symptomatic patients with CCh, especially in cases of mild-to-moderate grade CCh.

Author Information

Department of Ophthalmology, Seoul Veterans Hospital, Seoul, Korea.

Reprints: Sangkyung Choi, Department of Ophthalmology, Seoul Veterans Hospital, Doonchon2-dong, Gangdong-gu, Seoul 134-791, Korea (e-mail: drskchoi@hanmail.net).

Presented at the 106th annual meeting of the Korean Ophthalmological Society, November 4–6, 2011, Ilsan KINTEX, Kyungkido, Korea.

The authors state that they have no financial supports or conflicts of interest.

Received February 5, 2012

Accepted March 15, 2012

© 2013 by Lippincott Williams & Wilkins.